Frequency of variety of Candida species in women with Candida vaginitis referred to clinical centers of Mashhad, Iran

Document Type : Original Article


1 M.Sc. of Microbiology, School of Sciences, Islamic Azad University of Varamin, Pishva, Iran

2 MSc of Biochemistry, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

3 Assistant professor, Department of parasitology and Mycology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

4 Assistant professor, Department of Parasitology and Mycology, Cutaneous Leishmaniasis Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

5 Associate professor, Alborzi Clinical Microbiology Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran


Introduction: Vaginal candidiasis is a common genital tract infection in women caused by variety of Candida species. C. albicans is the most common species that are isolated from candidiasis, but in recent years other pathogenic Candida, such as C. glabrata, C. parapsilosis and C. tropicalis have been significantly increased. This study was performed with aim to identify the variety of candida species in women with Candida vaginitis.
Methods: This cross-sectional study was performed on 158 patients with symptoms of vaginitis referred to health centers of Mashhad University of Medical Sciences in 2013-2014. Positive cultures were collected from patients and were identified by using different diagnostic tests such as germ tube test, culture in Candida CHROM agar and corn meal agar with tween 80 medium, and assimilation test by API 20C AUX kit. Analysis of data was performed using SPSS statistical software (version 16) and chi-square test. PResults: In this study, 77.7% Candida albicans, 9% C. parapsilosis, 7% C. glabrata, 4% C. tropicalis and 1% C. kefir were isolated. Age group of 28-37 years had the highest rates of infection (%48.43). Among pregnant, the highest frequency was related to C. albicans (%86/66) and then, C. glabrata (%6.66), and in non-pregnant women, C. albicans  (%71.4) and then, C. glabrata (%11.90).
Conclusion: In this study, a significant increase was observed in the amount of C. glabrata and C. parapsilosis.


  1. Akbarzadeh M, Bonyadpoure B, Pacshir K, Mohagheghzadeh A. Causes and clinical symptoms of vaginal candidiasis in patients referring to selective clinics of Shiraz University of Medical Sciences (2009). Arak Med Univ J 2010; 13(3):12-20. (Persian).
  2. Bolouri F, Moghadami Tabrizi N, Davari Tanha F, Niroomand N, Azmoodeh A, Emami S, et al. Effectiveness of fluconazole for suppressive maintenance therapy in patients with RVVC: a randomized placebo-controlled study. Iran J Pharmaceut Res 2010; 8(4):307-13. (Persian).
  3. Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clin Microbiol Rev 2010; 23(2):253-73.
  4. Nezhad MM, Jouybari L, Sanagoo A, Haghdust Z, Mobasheri E. Prevalence of cervicovaginal infections in relationship with some factors in pap smear sampling. Iran J Obstet Gynecol Infertil 2014; 17(110):16-21. (Persian).
  5. Shahinfar S, Noman Pour B. The relationship between various individual characteristics and common vaginal infections among the women referring to payambar azam gynecology clinic in Kerman city. Iran J Obstet Gynecol Infertil 2015; 18(148):10-7. (Persian).
  6. Rivera-Sánchez R, Flores-Paz R, Arriaga-Alba M. [Identification of Candida species causing vaginitis in Mexican patients]. Enferm Infecc Microbiol Clin 2006; 24(10):634-6.
  7. Mahmoudabadi AZ, Najafyan M, Alidadi M. Clinical study of candida vaginitis in Ahvaz, Iran and susceptibility of agents to topical antifungal. Pak J Med Sci 2010; 26(3):607-10. (Persian).
  8. Panahi F, Kordbacheh P, Rezaie S, Zeini F, Zeraati H, Safara M. Determination of candida species in acute and recurrent candida vulvovaginitis. J Microbiol Knowledge 2009; 1(3):7-12. (Persian).
  9. Skandari A, Yadeghari M. Identification of important pathogenic yeast candida species in acute candidiasis using PCR. Trauma Mon 2008; 13(2):115-23. (Persian).
  10. Pirotta MV, Garland SM. Genital candida species detected in samples from women in Melbourne, Australia, before and after treatment with antibiotics. J Clin Microbiol 2006; 44(9):3213-7.
  11. Bagheri M, Mahmoudi Rad M, Mansouri A, Younespour S, Taheripanah R. A comparison between antifungal effect of Fumaria officinalis, Echinacea angustifolia, vinegar, and fluconazole against candida albicans and candida glabrata isolated from vagina candidiasis. Iran J Obstet Gynecol Infertil 2015; 17(136):1-9. (Persian).
  12. Bodey GP. Azole antifungal agents. Clin Infect Dis 1992; 14(Suppl 1):S161-9.
  13. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991; 325(18):1274-7.
  14. Najafzadeh MJ, Falahati M, Bagheri KP, Fata A, Fateh R. Flow cytometry susceptibility testing for conventional antifungal drugs and comparison with the NCCLS Broth Macrodilution Test. DARU J Pharm Sci 2009; 17(2):94-8.
  15. Pincus DH, Orenga S, Chatellier S. Yeast identification--past, present, and future methods. Med Mycol 2007; 45(2):97-121.
  16. Ellepola A, Morrison CJ. Laboratory diagnosis of invasive candidiasis. J Microbiol 2005; 43(5):65-84.
  17. Mahmoudi Rad M, Zafarghandi S, Abbasabadi B, Tavallaee M. The epidemiology of Candida species associated with vulvovaginal candidiasis in an Iranian patient population. Eur J Obstet Gynecol Reprod Biol 2011; 155(2):199-203.
  18. Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. candida glabrata, candida parapsilosis and candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev 2012; 36(2):288-305.
  19. Fan SR, Liu XP, Li JW. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of candida species isolates among patients in southern China from 2003 to 2006. J Obstet Gynaecol Res 2008; 34(4):561-6.
  20. Gandhi TN, Patel MG, Jain MR. Prospective study of vaginal discharge and prevalence of vulvovaginal candidiasis in a tertiary care hospital. Int J Curr Res Rev 2015; 7(1):34-8.
  21. 21 Hamad M, Kazandji N, Awadallah S, Allam H. Prevalence and epidemiological characteristics of vaginal candidiasis in the UAE. Mycoses 2014; 57(3):184-90.
  22. Fakhari E, Nakhaoda A, Emami M. Antifungal susceptibilities of candida species causing vulvovaginitis by disk diffusion. Jundishapur J Microbiol 2013; 1(2):7.
  23. Hospenthal DR, Beckius ML, Floyd KL, Horvath LL, Murray CK. Presumptive identification of candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar candida. Ann Clin Microbiol Antimicrob 2006; 5(1):1-5.
  24. Sobel JD. Vulvovaginal candidosis. Lancet 2007; 369(9577):1961-71.
  25. Li L, Redding S, Dongari-Bagtzoglou A. Candida glabrata, an emerging oral opportunistic pathogen. J Dent Res 2007; 86(3):204-15.
  26. Guzel AB, Ilkit M, Akar T, Burgut R, Demir SC. Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromID Candida agar versus CHROMagar candida for recovery and presumptive identification of vaginal yeast species. Med Mycol 2011; 49(1):16-25.
  27. Mahmoudi Rad M, Zafarghandi AS, Amel Zabihi M, Tavallaee M, Mirdamadi Y. Identification of candida species associated with vulvovaginal candidiasis by multiplex PCR. Infect Dis Obstet Gyneco 2012; 2012:1-5.
  28. Cetin M, Ocak S, Gungoren A, Hakverdi AU. Distribution of candida species in women with vulvovaginal symptoms and their association with different ages and contraceptive methods. Scand J Infect Dis 2007; 39(6-7):584-8.
  29. Murray CK, Beckius ML, Green JA, Hospenthal DR. Use of chromogenic medium in the isolation of yeasts from clinical specimens. J Med Microbiol 2005; 54(Pt 10):981-5.
  30. Kennedy MA, Sobel JD. Vulvovaginal candidiasis caused by non-albicans candida species: new insights. Curr Infect Dis Rep 2010; 12(6):465-70.
  31. Ahmad A, Khan AU. Prevalence of candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India. Eur J Obstet Gynecol Reprod Biol 2009; 144(1):68-71.
  32. Hedayati MT, Taheri Z, Galinimoghadam T, Aghili SR, Cherati JY, Mosayebi E. Isolation of different species of candida in patients with vulvovaginal candidiasis from Sari, Iran. Jundishapur J Microbiol 2015; 8(4):1-5.
  33. Safari M, Yazdanpanah B, Yazdanpanah S. High risk pregnancy and some of related factors in women who refered to vasouj health and medical centers. Sci J Hamadan Nurs Midwifery Faculty 2008; 16(2):18-28. (Persian).
  34. Aghamirian M, Keshavarz D, Jahani HH, Sadeghi GM. Agents associated with candida vulvovaginitis in women referred to health centers in Qazvin. J Qazvin Univ Med Sci 2007; 11(3):35-9. (Persian).
  35. Nwadioha SI, Egah DZ, Alao OO, Iheanacho E. Risk factors for vaginal candidiasis among women attending primary health care centers of Jos, Nigeria. J Clin Med Res 2010; 2(7):110-3.